Praxis Precision Medicines, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Praxis Precision Medicines, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q2 2024.
  • Praxis Precision Medicines, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.88M, a 1.78% increase year-over-year.
  • Praxis Precision Medicines, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $31.8M, a 20.3% increase year-over-year.
  • Praxis Precision Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $24.9M, a 13.1% decline from 2022.
  • Praxis Precision Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $28.6M, a 26% increase from 2021.
  • Praxis Precision Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $22.7M, a 335% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $31.8M $5.88M +$103K +1.78% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $31.7M $14.5M +$6.88M +90.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $24.9M $5.73M -$640K -10.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $25.5M $5.76M -$967K -14.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $26.5M $5.78M -$1.84M -24.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $28.3M $7.59M -$293K -3.72% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $28.6M $6.37M +$260K +4.26% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $28.3M $6.73M +$209K +3.21% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $28.1M $7.61M +$2.21M +40.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $25.9M $7.89M +$3.22M +69% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $22.7M $6.11M +$2.28M +59.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-07
Q3 2021 $20.4M $6.52M +$5.57M +584% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $14.8M $5.4M +$5.12M +1795% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $9.73M $4.67M +$4.52M +3074% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $5.21M $3.83M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $953K +$677K +245% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $285K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $147K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $276K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.